FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095102478> ?p ?o ?g. }

• W2095102478 endingPage "639.e5" @default.
• W2095102478 startingPage "639.e1" @default.
• W2095102478 abstract "Objective Ovarian cancer has the highest mortality of all the gynecologic malignancies with most patients diagnosed at late stages. Serum CA-125 is elevated in only half of patients with stages I-II. We identified 3 serum proteins (apolipoprotein A-1, transthyretin, and transferrin) for the detection of ovarian cancer and reported them combined with CA-125 to effectively detect early-stage mucinous tumors. The objectives of this study were to assess the effectiveness of the panel in detection of early-stage serous and endometrioid ovarian cancers. Study Design In all, 358 serum samples (control, benign adnexal masses, and early-stage and late-stage ovarian cancer) were obtained from the National Cancer Institute. The level of each marker was measured. Multiple logistic regression models were built to calculate sensitivity and specificity. Results When combined with CA-125, the panel detected early-stage cancer with a sensitivity of 96%. The highest sensitivity was seen for detection of endometrioid subtype of early-stage carcinomas (98%). Conclusion A panel of 4 serum biomarkers effectively detected early-stage ovarian cancers with the highest reported overall sensitivity of 96%. Endometrioid tumors were detected at early stages with a sensitivity of 98%. Prospective clinical analysis of the panel is needed to validate it as an effective screening tool for early-stage ovarian cancer. Ovarian cancer has the highest mortality of all the gynecologic malignancies with most patients diagnosed at late stages. Serum CA-125 is elevated in only half of patients with stages I-II. We identified 3 serum proteins (apolipoprotein A-1, transthyretin, and transferrin) for the detection of ovarian cancer and reported them combined with CA-125 to effectively detect early-stage mucinous tumors. The objectives of this study were to assess the effectiveness of the panel in detection of early-stage serous and endometrioid ovarian cancers. In all, 358 serum samples (control, benign adnexal masses, and early-stage and late-stage ovarian cancer) were obtained from the National Cancer Institute. The level of each marker was measured. Multiple logistic regression models were built to calculate sensitivity and specificity. When combined with CA-125, the panel detected early-stage cancer with a sensitivity of 96%. The highest sensitivity was seen for detection of endometrioid subtype of early-stage carcinomas (98%). A panel of 4 serum biomarkers effectively detected early-stage ovarian cancers with the highest reported overall sensitivity of 96%. Endometrioid tumors were detected at early stages with a sensitivity of 98%. Prospective clinical analysis of the panel is needed to validate it as an effective screening tool for early-stage ovarian cancer." @default.
• W2095102478 created "2016-06-24" @default.
• W2095102478 creator A5000506341 @default.
• W2095102478 creator A5009388960 @default.
• W2095102478 creator A5011923647 @default.
• W2095102478 creator A5018343544 @default.
• W2095102478 creator A5026372480 @default.
• W2095102478 creator A5056009731 @default.
• W2095102478 creator A5062169611 @default.
• W2095102478 creator A5081561534 @default.
• W2095102478 date "2009-06-01" @default.
• W2095102478 modified "2023-10-17" @default.
• W2095102478 title "Validation of serum biomarkers for detection of early-stage ovarian cancer" @default.
• W2095102478 cites W120268723 @default.
• W2095102478 cites W1985231226 @default.
• W2095102478 cites W1987266144 @default.
• W2095102478 cites W2005426017 @default.
• W2095102478 cites W2009368567 @default.
• W2095102478 cites W2026542164 @default.
• W2095102478 cites W2089317812 @default.
• W2095102478 cites W2090054751 @default.
• W2095102478 cites W2096116951 @default.
• W2095102478 cites W2096335059 @default.
• W2095102478 cites W2138482047 @default.
• W2095102478 cites W2151429141 @default.
• W2095102478 cites W2158083229 @default.
• W2095102478 doi "https://doi.org/10.1016/j.ajog.2008.12.042" @default.
• W2095102478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19285648" @default.
• W2095102478 hasPublicationYear "2009" @default.
• W2095102478 type Work @default.
• W2095102478 sameAs 2095102478 @default.
• W2095102478 citedByCount "87" @default.
• W2095102478 countsByYear W20951024782012 @default.
• W2095102478 countsByYear W20951024782013 @default.
• W2095102478 countsByYear W20951024782014 @default.
• W2095102478 countsByYear W20951024782015 @default.
• W2095102478 countsByYear W20951024782016 @default.
• W2095102478 countsByYear W20951024782017 @default.
• W2095102478 countsByYear W20951024782018 @default.
• W2095102478 countsByYear W20951024782019 @default.
• W2095102478 countsByYear W20951024782020 @default.
• W2095102478 countsByYear W20951024782021 @default.
• W2095102478 countsByYear W20951024782022 @default.
• W2095102478 countsByYear W20951024782023 @default.
• W2095102478 crossrefType "journal-article" @default.
• W2095102478 hasAuthorship W2095102478A5000506341 @default.
• W2095102478 hasAuthorship W2095102478A5009388960 @default.
• W2095102478 hasAuthorship W2095102478A5011923647 @default.
• W2095102478 hasAuthorship W2095102478A5018343544 @default.
• W2095102478 hasAuthorship W2095102478A5026372480 @default.
• W2095102478 hasAuthorship W2095102478A5056009731 @default.
• W2095102478 hasAuthorship W2095102478A5062169611 @default.
• W2095102478 hasAuthorship W2095102478A5081561534 @default.
• W2095102478 hasConcept C121608353 @default.
• W2095102478 hasConcept C126322002 @default.
• W2095102478 hasConcept C143998085 @default.
• W2095102478 hasConcept C146357865 @default.
• W2095102478 hasConcept C150173356 @default.
• W2095102478 hasConcept C151730666 @default.
• W2095102478 hasConcept C2780427987 @default.
• W2095102478 hasConcept C71924100 @default.
• W2095102478 hasConcept C86803240 @default.
• W2095102478 hasConcept C90924648 @default.
• W2095102478 hasConceptScore W2095102478C121608353 @default.
• W2095102478 hasConceptScore W2095102478C126322002 @default.
• W2095102478 hasConceptScore W2095102478C143998085 @default.
• W2095102478 hasConceptScore W2095102478C146357865 @default.
• W2095102478 hasConceptScore W2095102478C150173356 @default.
• W2095102478 hasConceptScore W2095102478C151730666 @default.
• W2095102478 hasConceptScore W2095102478C2780427987 @default.
• W2095102478 hasConceptScore W2095102478C71924100 @default.
• W2095102478 hasConceptScore W2095102478C86803240 @default.
• W2095102478 hasConceptScore W2095102478C90924648 @default.
• W2095102478 hasIssue "6" @default.
• W2095102478 hasLocation W20951024781 @default.
• W2095102478 hasLocation W20951024782 @default.
• W2095102478 hasOpenAccess W2095102478 @default.
• W2095102478 hasPrimaryLocation W20951024781 @default.
• W2095102478 hasRelatedWork W183804059 @default.
• W2095102478 hasRelatedWork W1985790301 @default.
• W2095102478 hasRelatedWork W2005585032 @default.
• W2095102478 hasRelatedWork W2014221109 @default.
• W2095102478 hasRelatedWork W2314460022 @default.
• W2095102478 hasRelatedWork W2329386257 @default.
• W2095102478 hasRelatedWork W2418957561 @default.
• W2095102478 hasRelatedWork W2607392433 @default.
• W2095102478 hasRelatedWork W4322709813 @default.
• W2095102478 hasRelatedWork W1997140422 @default.
• W2095102478 hasVolume "200" @default.
• W2095102478 isParatext "false" @default.
• W2095102478 isRetracted "false" @default.
• W2095102478 magId "2095102478" @default.
• W2095102478 workType "article" @default.